Evidence map›Paper›PMID 29483658›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2018

Muscarinic M

Alice E Berizzi, Christina J Perry, David M Shackleford, Craig W Lindsley, Carrie K Jones, Nicola A Chen, Patrick M Sexton, Arthur Christopoulos, Christopher J Langmead, Andrew J Lawrence

Open access · hybridAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Discovery of a potent MBioorganic & medicinal chemistry letters · 2022
    Article
  10. Discovery of a potent MBioorganic & medicinal chemistry letters · 2022
    Article
  11. MPharmacology research & perspectives · 2022
    Article
  12. Article
  13. Review
  14. Article
  15. Acetylcholine Muscarinic MBiological psychiatry · 2020
    Article
  16. Crystal structure of the MProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  17. Review
  18. Article
  19. Acute Negative Allosteric Modulation of MACS chemical neuroscience · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Alice E BerizziDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 3052, Australia.
Christina J PerryThe Florey Institute of Neuroscience and Mental Health, Parkville, VIC, 3052, Australia.
David M ShacklefordCentre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 3052, Australia.
Craig W LindsleyDepartments of Pharmacology and Chemistry, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, 37232, USA.
Carrie K JonesDepartments of Pharmacology and Chemistry, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN, 37232, USA.
Nicola A ChenThe Florey Institute of Neuroscience and Mental Health, Parkville, VIC, 3052, Australia.
Patrick M SextonDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 3052, Australia.
Arthur ChristopoulosDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 3052, Australia. Arthur.Christopoulos@monash.edu.
Christopher J LangmeadDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, 3052, Australia. Christopher.Langmead@monash.edu.
Andrew J LawrenceThe Florey Institute of Neuroscience and Mental Health, Parkville, VIC, 3052, Australia. Andrew.Lawrence@florey.edu.au.ORCID http://orcid.org/0000-0001-6836-727X
Monash University · AUDiscovery Institute · USFlorey Institute of Neuroscience and Mental Health · AUVanderbilt University · USThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the cost to both individual and society, alcohol use disorders (AUDs) remain a major health risk within society, and both relapse and heavy drinking are still poorly controlled with current medications. Here we demonstrate for the first time that a centrally active and selective negative allosteric modulator for the rat M

Indexed as

AnimalsConditioning, OperantCorpus StriatumCuesDrug-Seeking BehaviorEthanolImidazolesIndolesLocomotionMaleMicroinjectionsRatsReceptor, Muscarinic M5Self AdministrationSucroseVarenicline9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo(2,1-a)isoindol-5(9bH)-oneEthanolImidazolesIndolesReceptor, Muscarinic M5SucroseVarenicline

Identifiers

PMID29483658
PMCPMC5983544
OpenAlexW2790002915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.